大麻素受体1（CNR1）基因多态性与大麻依赖之间关联的证据。
Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence.
作者信息
Agrawal Arpana, Wetherill Leah, Dick Danielle M, Xuei Xiaoling, Hinrichs Anthony, Hesselbrock Victor, Kramer John, Nurnberger John I, Schuckit Marc, Bierut Laura J, Edenberg Howard J, Foroud Tatiana
机构信息
Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
出版信息
Am J Med Genet B Neuropsychiatr Genet. 2009 Jul 5;150B(5):736-40. doi: 10.1002/ajmg.b.30881.
Abstract
Genomic studies of cannabis use disorders have been limited. The cannabinoid receptor 1 gene (CNR1) on chromosome 6q14-15 is an excellent candidate gene for cannabis dependence due to the important role of the G-protein coupled receptor encoded by this gene in the rewarding effects of Delta9-tetrahydrocannabinol. Previous studies have found equivocal evidence for an association between SNPs in CNR1 and a general vulnerability to substance use disorders. We investigate the association between 9 SNPs spanning CNR1 and cannabis dependence in 1,923 individuals. Two SNPs that were previously associated with cannabis dependence in other studies were also significant with this phenotype in our analyses [rs806368 (P = 0.05) and rs806380 (P = 0.009)]. Haplotype analyses revealed the association to be largely driven by the SNP rs806380. These results suggest a role for the cannabinoid receptor 1 gene in cannabis dependence.
摘要
对大麻使用障碍的基因组学研究一直很有限。位于6号染色体q14 - 15区域的大麻素受体1基因（CNR1）是大麻依赖的一个极佳候选基因，因为该基因编码的G蛋白偶联受体在Δ9 - 四氢大麻酚的奖赏效应中发挥着重要作用。先前的研究发现，CNR1基因单核苷酸多态性（SNP）与物质使用障碍的总体易感性之间的关联证据并不明确。我们在1923名个体中研究了跨越CNR1基因的9个SNP与大麻依赖之间的关联。在我们的分析中，之前在其他研究中与大麻依赖相关的两个SNP也与该表型显著相关[rs806368（P = 0.05）和rs806380（P = 0.009）]。单倍型分析表明，这种关联在很大程度上是由SNP rs806380驱动的。这些结果表明大麻素受体1基因在大麻依赖中发挥作用。
相似文献
1
Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence.大麻素受体1（CNR1）基因多态性与大麻依赖之间关联的证据。
Am J Med Genet B Neuropsychiatr Genet. 2009 Jul 5;150B(5):736-40. doi: 10.1002/ajmg.b.30881.
2
The association between cannabinoid receptor 1 gene (CNR1) and cannabis dependence symptoms in adolescents and young adults.青少年和青年中大麻素受体1基因（CNR1）与大麻依赖症状之间的关联。
Drug Alcohol Depend. 2009 Sep 1;104(1-2):11-6. doi: 10.1016/j.drugalcdep.2009.01.022. Epub 2009 May 14.
3
Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents.与青少年较少大麻依赖症状相关的大麻受体单倍型
Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):895-901. doi: 10.1002/ajmg.b.30378.
4
and variation and affective states induced by marijuana smoking.并且大麻吸烟引起的变异和情感状态。
Am J Drug Alcohol Abuse. 2019;45(5):514-526. doi: 10.1080/00952990.2019.1614596. Epub 2019 Jun 11.
5
Developmentally Specific Associations Between CNR1 Genotype and Cannabis Use Across Emerging Adulthood.新兴成年期CNR1基因分型与大麻使用之间的发育特异性关联。
J Stud Alcohol Drugs. 2017 Sep;78(5):686-695. doi: 10.15288/jsad.2017.78.686.
6
Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.大麻素受体 1 基因多态性与大麻滥用对精神分裂症患者脑白质和认知功能障碍的交互作用。
Schizophr Res. 2011 May;128(1-3):66-75. doi: 10.1016/j.schres.2011.02.021. Epub 2011 Mar 21.
7
MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse.MAPK14 和 CNR1 基因变异的相互作用：对滥用大麻的精神分裂症患者脑容量不足的影响。
Psychol Med. 2013 Mar;43(3):619-31. doi: 10.1017/S0033291712001559. Epub 2012 Jul 31.
8
Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes.大麻戒断与渴望：大麻素受体1（CNR1）和脂肪酸酰胺水解酶（FAAH）基因的影响
Addiction. 2008 Oct;103(10):1678-86. doi: 10.1111/j.1360-0443.2008.02292.x. Epub 2008 Aug 14.
9
Impulsivity, variation in the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes, and marijuana-related problems.冲动性、大麻素受体（CNR1）和脂肪酸酰胺水解酶（FAAH）基因的变异以及与大麻相关的问题。
J Stud Alcohol Drugs. 2013 Nov;74(6):867-78. doi: 10.15288/jsad.2013.74.867.
10
Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families.酒精依赖超高风险家庭及对照家庭后代大麻使用和依赖的纵向预测因素
Am J Med Genet B Neuropsychiatr Genet. 2016 Apr;171B(3):383-95. doi: 10.1002/ajmg.b.32417. Epub 2016 Jan 12.
引用本文的文献
1
analyses of the involvement of GPR55, CB1R and TRPV1: response to THC, contribution to temporal lobe epilepsy, structural modeling and updated evolution.对GPR55、CB1R和TRPV1参与情况的分析：对四氢大麻酚的反应、对颞叶癫痫的作用、结构建模及最新进化情况
Front Neuroinform. 2024 Feb 7;18:1294939. doi: 10.3389/fninf.2024.1294939. eCollection 2024.
2
Cannabinoids and Multiple Sclerosis: A Critical Analysis of Therapeutic Potentials and Safety Concerns.大麻素与多发性硬化症：对治疗潜力和安全问题的批判性分析
Pharmaceutics. 2023 Apr 5;15(4):1151. doi: 10.3390/pharmaceutics15041151.
3
Association of Dopamine Transporter Gene (DAT1) 40 bp 3' UTR VNTR Polymorphism (rs28363170) and Cannabis Use Disorder.多巴胺转运体基因（DAT1）3'非翻译区40bp可变数目串联重复序列多态性（rs28363170）与大麻使用障碍的关联
Subst Abuse. 2023 Mar 31;17:11782218231163696. doi: 10.1177/11782218231163696. eCollection 2023.
4
The genetic aetiology of cannabis use: from twin models to genome-wide association studies and beyond.大麻使用的遗传病因学：从双胞胎模型到全基因组关联研究及其他。
Transl Psychiatry. 2022 Nov 21;12(1):489. doi: 10.1038/s41398-022-02215-2.
5
FOXN3 and GDNF Polymorphisms as Common Genetic Factors of Substance Use and Addictive Behaviors.FOXN3和GDNF基因多态性作为物质使用和成瘾行为的常见遗传因素
J Pers Med. 2022 Apr 26;12(5):690. doi: 10.3390/jpm12050690.
6
Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders.精神疾病中环核苷酸系统的分子改变。
Int J Mol Sci. 2022 Apr 26;23(9):4764. doi: 10.3390/ijms23094764.
7
Biomarkers of the Endocannabinoid System in Substance Use Disorders.物质使用障碍的内源性大麻素系统生物标志物。
Biomolecules. 2022 Mar 3;12(3):396. doi: 10.3390/biom12030396.
8
and Polymorphisms in the Endocannabinoid System and Alcohol-Related Sleep Quality.内源性大麻素系统中的多态性与酒精相关的睡眠质量
Front Psychiatry. 2021 Sep 9;12:712178. doi: 10.3389/fpsyt.2021.712178. eCollection 2021.
9
A systems omics-based approach to decode substance use disorders and neuroadaptations.基于系统组学的方法来解码物质使用障碍和神经适应。
Neurosci Biobehav Rev. 2021 Nov;130:61-80. doi: 10.1016/j.neubiorev.2021.08.016. Epub 2021 Aug 17.
10
Receptor-Dependent and Independent Regulation of Voltage-Gated Ca Channels and Ca-Permeable Channels by Endocannabinoids in the Brain.脑内内源性大麻素对电压门控钙通道和钙通透通道的受体依赖性和非受体依赖性调节。
Int J Mol Sci. 2021 Jul 29;22(15):8168. doi: 10.3390/ijms22158168.
本文引用的文献
1
The Collaborative Study on the Genetics of Alcoholism.酒精中毒遗传学合作研究
Alcohol Health Res World. 1995;19(3):228-236.
2
The incentive salience of alcohol: translating the effects of genetic variant in CNR1.酒精的动机显著性：解读CNR1基因变异的影响
Arch Gen Psychiatry. 2008 Jul;65(7):841-50. doi: 10.1001/archpsyc.65.7.841.
3
Cannabinoid receptor 1 gene association with nicotine dependence.大麻素受体1基因与尼古丁依赖的关联。
Arch Gen Psychiatry. 2008 Jul;65(7):816-24. doi: 10.1001/archpsyc.65.7.816.
4
An autosomal linkage scan for cannabis use disorders in the nicotine addiction genetics project.尼古丁成瘾遗传学项目中针对大麻使用障碍的常染色体连锁扫描。
Arch Gen Psychiatry. 2008 Jun;65(6):713-21. doi: 10.1001/archpsyc.65.6.713.
5
Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence.大麻戒断与依赖的药物治疗和心理治疗
Expert Rev Neurother. 2008 Mar;8(3):479-91. doi: 10.1586/14737175.8.3.479.
6
Update on pharmacologic options for smoking cessation treatment.戒烟治疗的药物选择最新进展。
Am J Med. 2008 Apr;121(4 Suppl 1):S20-31. doi: 10.1016/j.amjmed.2008.01.016.
7
CB1 cannabinoid antagonists: structure-activity relationships and potential therapeutic applications.CB1大麻素拮抗剂：构效关系及潜在治疗应用
Curr Top Med Chem. 2008;8(3):205-30. doi: 10.2174/156802608783498050.
8
Linkage scan for quantitative traits identifies new regions of interest for substance dependence in the Collaborative Study on the Genetics of Alcoholism (COGA) sample.酒精中毒遗传学合作研究（COGA）样本中对数量性状的连锁扫描确定了物质依赖新的感兴趣区域。
Drug Alcohol Depend. 2008 Jan 11;93(1-2):12-20. doi: 10.1016/j.drugalcdep.2007.08.015. Epub 2007 Oct 17.
9
Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.用于戒烟的1型大麻素受体拮抗剂（利莫那班）
Cochrane Database Syst Rev. 2007 Jul 18(3):CD005353. doi: 10.1002/14651858.CD005353.pub2.
10
CNR1 variation modulates risk for drug and alcohol dependence.大麻素受体1（CNR1）基因变异调节药物和酒精依赖的风险。
Biol Psychiatry. 2007 Sep 15;62(6):616-26. doi: 10.1016/j.biopsych.2006.12.004. Epub 2007 May 23.
Zotero 插件